Company
CEO
2022-01-01–present
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Jon Cohen is recorded as CEO at Opko Health, Inc. (OPK) and Analyst at BioReference Laboratories. The company reported in an 8-K filed August 17, 2026 that Jon Cohen resigned as director, effective August 17, 2026. The proxy statement of the company reports total compensation of $1,893,057 for Jon Cohen in fiscal 2024, including a base salary of $600,000. Disclosed compensation is on record for 4 fiscal years. Jon Cohen has spoken on 12 earnings calls across 2 companies, most recently on May 6, 2025.
“Effective upon the consummation of the Merger, each of Douglas Braunstein, Jon R. Cohen, Swati Abbott, Liat Ben-Zur, Michael Hansen, Madhu Pawar, Erez Shachar, Curtis Warfield and Jacqueline Yeaney resigned from the board of directors of the Company (the "Board") and from any and all committees of the Board on which they served and ceased to be directors of the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
BioReference Laboratories
Analyst
Source not stated
Organization not stated
CEO
Proxy statement
Start not stated–present
Organization not stated
Board Member
Proxy statement
2022-01-01–2026-08-17
Recorded roles and call appearances connecting this person to public companies.
Company
CEO
2022-01-01–present
Other people whose current roles at this company are on record from its filings.
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | — | — | $600,000 | $1,893,057 |
| 2023 | — | | $600,000 | $1,337,323 |
| 2022 | — | | $92,172 | $2,747,622 |
| 2021 | — | | — | — |
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
Talkspace, Inc. Q4 FY2024 Earnings Call
Talkspace, Inc. Q2 FY2024 Earnings Call
Talkspace, Inc. Q1 FY2024 Earnings Call
Talkspace, Inc. Q4 FY2023 Earnings Call
Talkspace, Inc. Q3 FY2023 Earnings Call
Talkspace, Inc. Q2 FY2023 Earnings Call
Talkspace, Inc. Q1 FY2023 Earnings Call
Talkspace, Inc. Q4 FY2022 Earnings Call
Talkspace, Inc. Q3 FY2022 Earnings Call